Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Metformin

  • You have access
    Knockdown of NUPR1 Enhances the Sensitivity of Non-small-cell Lung Cancer Cells to Metformin by AKT Inhibition
    YU JIN KIM, SUNG-EUN HONG, SE-KYEONG JANG, KI SOO PARK, CHUN-HO KIM, IN-CHUL PARK and HYEON-OK JIN
    Anticancer Research July 2022, 42 (7) 3475-3481; DOI: https://doi.org/10.21873/anticanres.15834
  • You have access
    Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
    CHIARA CICCARESE, ROBERTO IACOVELLI, SEBASTIANO BUTI, FRANCESCA PRIMI, SERENA ASTORE, FRANCESCO MASSARI, MIRIAM GRAZIA FERRARA, GIUSEPPE PALERMO, NAZARIO FOSCHI, VALERIO IACOVELLI, ERNESTO ROSSI, GIOVANNI SCHINZARI, PIERLUIGI BOVE, PIERFRANCESCO BASSI, EMILIO BRIA and GIAMPAOLO TORTORA
    Anticancer Research March 2022, 42 (3) 1487-1493; DOI: https://doi.org/10.21873/anticanres.15620
  • You have access
    Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study
    WON IL JANG, MI-SOOK KIM, JAE-HOON JEONG, WONWOO KIM and JAE SUNG KIM
    Anticancer Research February 2022, 42 (2) 867-876; DOI: https://doi.org/10.21873/anticanres.15544
  • You have access
    Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising Drug
    CHARUPONG SAENGBOONMEE, THANACHAI SANLUNG and SOPIT WONGKHAM
    Anticancer Research December 2021, 41 (12) 5913-5918; DOI: https://doi.org/10.21873/anticanres.15410
  • You have access
    Inhibition of AKT Enhances the Sensitivity of NSCLC Cells to Metformin
    SE-KYEONG JANG, SUNG-EUN HONG, DA-HEE LEE, JI YEA KIM, JI-YOUNG KIM, JUNGIL HONG, IN-CHUL PARK and HYEON-OK JIN
    Anticancer Research July 2021, 41 (7) 3481-3487; DOI: https://doi.org/10.21873/anticanres.15135
  • You have access
    Effect of Metformin in Combination With Trametinib and Paclitaxel on Cell Survival and Metastasis in Melanoma Cells
    YOUNGKI LEE and DEOKBAE PARK
    Anticancer Research March 2021, 41 (3) 1387-1399; DOI: https://doi.org/10.21873/anticanres.14896
  • You have access
    Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes
    ELINA URPILAINEN, REETTA ARIMA, PEETER KARIHTALA, ULLA PUISTOLA and ANNE AHTIKOSKI
    Anticancer Research February 2021, 41 (2) 821-828; DOI: https://doi.org/10.21873/anticanres.14834
  • You have access
    Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer
    MARTIN SVATON, MILADA ZEMANOVA, PETRA ZEMANOVA, JURAJ KULTAN, ONDREJ FISCHER, JANA SKRICKOVA, LENKA JAKUBIKOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, MICHAL JIROUSEK, JANA KREJCI, DANIEL KREJCI, ONDREJ BILEK, JIRI BLAZEK, KAROLINA HURDALKOVA, MAGDA BARINOVA and BOHUSLAV MELICHAR
    Anticancer Research April 2020, 40 (4) 2209-2217; DOI: https://doi.org/10.21873/anticanres.14182
  • You have access
    Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis
    HIROKI YAMANA, KIYOHITO KATO, HIDEKI KOBARA, SHINTARO FUJIHARA, KOJI FUJITA, DAISUKE NAMIMA, NAOKI FUJITA, KIYOYUKI KOBAYASHI, HIDEKI KAMADA, ASAHIRO MORISHITA, KUNIHIKO TSUTSUI, HISAKAZU IWAMA and TSUTOMU MASAKI
    Anticancer Research January 2020, 40 (1) 121-132; DOI: https://doi.org/10.21873/anticanres.13933
  • You have access
    Metformin Prevents Peritoneal Dissemination via Immune-suppressive Cells in the Tumor Microenvironment
    TAKANORI HIRAYAMA, YASUHIRO NAGATA, MIKAKO NISHIDA, MITSUTOSHI MATSUO, SHINICHIRO KOBAYASHI, AKIRA YONEDA, KENGO KANETAKA, HEIICHIRO UDONO and SUSUMU EGUCHI
    Anticancer Research September 2019, 39 (9) 4699-4709; DOI: https://doi.org/10.21873/anticanres.13652

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire